Medkonsta - Company finances
|
EUR
|
2018
From: 2018-02-26
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 4,602 | 22,335 | 34,432 | 26,963 | 24,082 | 19,122 | 26,340 | 32,869 |
| Profit before tax | 347 | 6,809 | 10,987 | 12,363 | 5,865 | 7,615 | 13,814 | 4,345 |
| Net profit | 347 | 6,548 | 10,554 | 11,859 | 5,756 | 7,519 | 13,334 | 4,341 |
| Equity | 347 | 6,895 | 13,951 | 21,300 | 22,056 | 19,968 | 25,502 | 22,324 |
| Liabilities | - | - | - | - | 2,113 | 200 | 1,046 | 370 |
| Non-current assets | 13,713 | 11,536 | 9,656 | 10,745 | 9,948 | 10,852 | 8,937 | 10,510 |
| Current assets | 470 | 6,852 | 13,341 | 11,890 | 14,221 | 9,316 | 17,611 | 12,184 |
| Total assets | 14,183 | 18,388 | 22,997 | 22,635 | 24,169 | 20,168 | 26,548 | 22,694 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 227 | 105 | 1,581 |
|
Financial indicators
|
||||||||
| Revenue change y/y | - | +385.3% | +54.2% | -21.7% | -10.7% | -20.6% | +37.7% | +24.8% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 2.4% | 35.6% | 45.9% | 52.4% | 23.8% | 37.3% | 50.2% | 19.1% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 100.0% | 95.0% | 75.7% | 55.7% | 26.1% | 37.7% | 52.3% | 19.4% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 7.5% | 29.3% | 30.7% | 44.0% | 23.9% | 39.3% | 50.6% | 13.2% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 7.5% | 30.5% | 31.9% | 45.9% | 24.4% | 39.8% | 52.4% | 13.2% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | 0.1 | 0.0 | 0.0 | 0.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | - | - | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Medkonsta - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-11-01 | 2025-11-30 | 38.44 |
Medkonsta - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-06-28 | 2026-07-07 | 0.88 |
| 2025-08-28 | 2025-09-23 | 0.26 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Medkonsta, MB (code 304777490) is a Lithuanian small partnership engaged in new construction. In the latest financial year, 2025, the company generated revenue of €32.9K, up 24.8% year on year and 71.9% over two years. Net profit was €4.3K, which corresponded to a 13.2% profit margin. This was a weaker result than in 2024, when revenue reached €26.3K and net profit €13.3K, after €19.1K of revenue and €7.5K of net profit in 2023. The decline in profitability in 2025 came despite continued sales growth. At year-end 2025, total assets stood at €22.7K, equity at €22.3K and liabilities at €370, indicating a very strong equity base. Key efficiency indicators were solid, with return on equity at 19.4%, return on assets at 19.1% and asset turnover at 1.45x. The debt-to-equity ratio was 0.02, reflecting minimal leverage.